Democrats charge ahead on Pelosi drug pricing bill

Washington Examiner Politics 1 month ago

House Democrats rejected an amendment to pass bipartisan drug pricing legislation during a fraught markup Thursday, choosing instead to charge ahead on Speaker Nancy Pelosi's partisan bill.

The amendment from Rep. Greg Walden was a package of four bills that House Republicans and Democrats had worked on together to help lower prescription drug costs and bring more generics to market. Walden urged Democrats to support it because the Pelosi bill would not become law under a GOP-controlled Senate.

"I’m offering this amendment in the hopes of moving away from this unnecessary, political exercise in futility and returning to a productive, bipartisan process that will lower the cost of drugs for Americans," Walden said.

But Democrats said the package was inadequate and opted to press ahead on the Pelosi bill, the Lower Drug Costs Now Act. The party has long wanted to let the government negotiate prescription drugs as a way to lower prices, and the Pelosi bill would allow it for up to 250 drugs so that they're closer to what people pay in other developed countries. The bill would also penalize drug companies that don't negotiate.

Democratic leaders hope to have a floor vote on the bill the week of Oct. 28, which will help to signal what type of action the party would take on drug prices if voters were to elect a Democrat to the White House.

During the markup Thursday, in the House Energy and Commerce Committee, Republicans blasted Democrats for sidelining other legislation they had worked on all year in favor of the Pelosi bill.

"It's something we should have on the House floor. You would get over 400 votes for that bill," said Rep. Steve Scalise, the minority whip.

"This is not what the public wants, they want us to work together," said Rep. David McKinley of West Virginia, urging Democrats to "put down your pitchforks and torches of animosity."

But Rep. Anna Eshoo, who leads the health subcommittee, said the differences between Republicans and Democrats about how to take on drug prices were too vast and that she believed Republican ideas weren't effective enough.

"This is a big split between the two parties because we do believe that direct negotiations is the best way to bring down significantly the cost of drugs," she said.

Democrats also dared President Trump to support the legislation, noting that he had said when he was running for office that he thought the government should be allowed to negotiate drug prices.

"Maybe he’ll come out and say he loves it, and maybe we’ll get some of our colleagues in the House and Senate to change their minds," said Rep. Frank Pallone, who leads the committee.

Of the Pelosi bill, Trump has said only that it was "great to see" drug pricing measures introduced, adding of the issue, "Let's get it done in a bipartisan way!"

The committee didn't begin marking up the Pelosi bill until four hours into the hearing. Republicans repeatedly pointed to a Congressional Budget Office analysis that projected as many as 15 new treatments may never make it to market if the bill were to become law. Price fixing, they said, would stifle future treatments and cures for devastating illnesses such as Lou Gehrig's disease or Alzheimer's disease.

But Democrats disagreed with the assessment. The argument that innovation would suffer, countered Democratic Rep. Jan Schakowsky of Illinois, was “just a ploy to protect a greedy industry. ” House Democrats instead focused on the $345 billion in savings to the government over seven years that were expected under the bill.

Republicans had more than 200 other amendments prepared to file. Democrats rejected one Republican amendment that would have blocked the federal government from negotiating the price of future drugs to treat Alzheimer's disease, and another that would have required savings on insulin to be passed onto patients, instead favoring a lower price to begin with rather than trying to work within a confusing rebate system.

Pelosi announced Thursday morning that the legislation will be renamed for Rep. Elijah Cummings, who died Thursday morning and during his time in Congress fought to have the government negotiate drug prices.


Source link
Read also:
Alternet › 4 days ago
House Speaker Nancy Pelosi, faced with a united front of progressive Democrats pushing back against a drug pricing bill seen as insufficient, blinked on Tuesday and handed her party’s left…
Forbes › Finance › 1 week ago
The House Democrats' Medicare drug bill is about drug pricing, but also about other benefits--and politics.
Fox News › Politics › 5 days ago
House Speaker Nancy Pelosi, D-Calif., is facing intraparty opposition before a vote on drug pricing legislation that progressives have complained doesn't go far enough in regulating costs for Americans.
The Hill › 2 days ago
The House Democrats' campaign arm on Friday launched a bilingual campaign to shore up support among voters in swing districts, touting a drug pricing bill that passed the House the day before.The Democratic Congres...
Axios › Finance › 2 weeks ago
The Senate's drug pricing bill would likely be better for the pharmaceutical industry than either President Trump's agenda or House Speaker Nancy Pelosi's.Between the lines: Industry opposes anything that would hurt its bottom line, but of those three...
Reuters › Politics › 2 months ago
House Democrats' plan to help lower the cost of medicines should be a priority for the White House, U.S. House Speaker Nancy Pelosi told reporters on Thursday at an event unveiling their prescription drug pricing plan.
CNBC › 1 week ago
The report from the administration suggests far greater consequences for both the drug industry and American consumers if Pelosi's bill is enacted.
Fox News › Politics › 4 days ago
Add businessman Steve Forbes to the long list of people criticizing House Speaker Nancy Pelosi's drug prices legislation -- a prominent part of Democrats' agenda that was eventually altered amid intraparty backlash.
Washington Times › Politics › 1 month ago
House Speaker Nancy Pelosi's push to impose pricing caps on prescription drugs has run into solid opposition from Republican lawmakers and conservative groups who have branded it a "socialist fantasy."
Washington Examiner › Politics › 5 days ago
Advocacy organizations for patients with serious illnesses have been noticeably silent about House Speaker Nancy Pelosi's bill to lower drug prices ahead of a high-profile House vote this week.
Sign In

Sign in to follow sources and tags you love, and get personalized stories.

Continue with Google
OR